Form 4: CoreWeave CDO Sells $2.32M in Stock via 10b5-1 Plan

CoreWeave's Chief Development Officer, Brannin McBee, executed pre-planned sales of Class A Common Stock totaling 26,000 shares on January 12, 2026.

Summary

• Brannin McBee, CoreWeave's Chief Development Officer, reported transactions involving the company's Class A and Class B Common Stock.
• On January 12, 2026, McBee converted 25,000 shares of Class B Common Stock into Class A Common Stock, held indirectly through the Canis Major 2025 GRAT.
• On the same date, an additional 1,000 shares of Class B Common Stock were converted into Class A Common Stock, held indirectly through the Canis Minor 2025 Family Trust LLC.
• Following these conversions, a total of 26,000 shares of Class A Common Stock were sold in multiple transactions.
• The sales were executed pursuant to a Rule 10b5-1 trading plan adopted by McBee on September 2, 2025.
• The shares from the Canis Major 2025 GRAT (25,000 shares) were sold at weighted average prices ranging from $78.5305 to $91.7377 per share.
• The shares from the Canis Minor 2025 Family Trust LLC (1,000 shares) were sold at weighted average prices ranging from $78.83 to $91.87 per share.
• The estimated total value of the shares sold is approximately $2,317,390.06.
• After these transactions, the Canis Major 2025 GRAT holds 5,825,000 shares of Class B Common Stock, and the Canis Minor 2025 Family Trust LLC holds 127,000 shares of Class B Common Stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While insider selling can sometimes be viewed negatively, the transactions were executed under a pre-arranged Rule 10b5-1 trading plan, which mitigates concerns about sales being based on new, adverse material non-public information. This indicates a planned diversification or liquidity event rather than a reaction to company-specific news.

Positives

• The sales were conducted under a pre-arranged Rule 10b5-1 trading plan, adopted on September 2, 2025, indicating the transactions were not based on recent material non-public information.
• The transactions demonstrate adherence to SEC regulations for insider trading, promoting transparency and reducing the risk of market manipulation.

Negatives

• The Chief Development Officer sold a significant number of shares, totaling 26,000 Class A Common Stock, which could be perceived by some investors as a lack of confidence in the company's near-term prospects.
• The estimated total value of shares sold, approximately $2.32 million, represents a substantial divestment by a key executive.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

This Form 4 filing is a standard disclosure of insider trading activity and does not provide information related to broader industry trends or competitive landscape.

Related Party Transactions

• The sales of Class A Common Stock were made from the Canis Major 2025 GRAT, of which the reporting person, Brannin McBee, is the sole trustee and beneficiary.
• Additional sales were made from the Canis Minor 2025 Family Trust LLC, for which Brannin McBee serves as manager.

Stakeholder Impact

• Shareholders may interpret the significant insider selling as a signal, potentially influencing their perception of the company's stock value, despite the sales being pre-planned.
• The transparency provided by the Rule 10b5-1 plan helps maintain investor confidence in the fairness and legality of insider transactions.

Next Steps

• The filing indicates that it is 'Part 3 of 4' for this reporting person, suggesting further transaction reports may follow. No other specific future actions or milestones for the company are mentioned.

Key Dates

Recommendation

This Form 4 filing details pre-planned insider sales by a Chief Development Officer. While the sale of approximately $2.32 million in stock is substantial, the execution under a Rule 10b5-1 plan adopted several months prior (September 2, 2025) suggests these are for personal financial planning, diversification, or liquidity rather than a reaction to new, negative company developments. Therefore, it does not inherently signal a change in the company's fundamental outlook. Investors should monitor future filings and company performance, but this specific transaction alone does not warrant a change from a 'hold' position.

Keywords

CoreWeave, CRWV, Insider Trading, Form 4, Stock Sale, 10b5-1 Plan, Beneficial Ownership, Chief Development Officer, Equity Sales, SEC Filing